Literature DB >> 19474290

Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor.

Elie Abed1, Robert Moreau.   

Abstract

Bone is a dynamic tissue that is continuously being remodeled throughout life. Specialized cells called osteoclasts transiently break down old bone (resorption process) at multiple sites as other cells known as osteoblasts are replacing it with new tissue (bone formation). Usually, both resorption and formation processes are in balance and thereby maintain skeletal strength and integrity. This equilibrium is assured by the coordination of proliferation, migration, differentiation, and secretory functions of the osteoblasts, which are essential for adequate formation and resorption processes. Disturbances of this equilibrium may lead to decreased bone mass (osteoporosis), increased bone fragility, and susceptibility to fractures. Epidemiological studies have linked insufficient dietary magnesium (Mg(2+)) intake in humans with low bone mass and osteoporosis. Here, we investigated the roles of Mg(2+) and melastatin-like transient receptor potential 7 (TRPM7), known as Mg(2+) channels, in human osteoblast cell proliferation and migration induced by platelet-derived growth factor (PDGF), which has been involved in the bone remodeling process. PDGF promoted an influx of Mg(2+), enhanced cell migration, and stimulated the gene expression of TRPM7 channels in human osteoblast MG-63 cells. The stimulation of osteoblast proliferation and migration by PDGF was significantly reduced under culture conditions of low extracellular Mg(2+) concentrations. Silencing TRPM7 expression in osteoblasts by specific small interfering RNA prevented the induction by PDGF of Mg(2+) influx, proliferation, and migration. Our results indicate that extracellular Mg(2+) and TRPM7 are important for PDGF-induced proliferation and migration of human osteoblasts. Thus Mg(2+) deficiency, a common condition among the general population, may be associated with altered osteoblast functions leading to inadequate bone formation and the development of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474290     DOI: 10.1152/ajpcell.00614.2008

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  38 in total

1.  Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.

Authors:  Nelson S Yee; Weiqiang Zhou; Minsun Lee; Rosemary K Yee
Journal:  Cancer Lett       Date:  2011-12-11       Impact factor: 8.679

2.  TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cells.

Authors:  Daan Visser; Michiel Langeslag; Katarzyna M Kedziora; Jeffrey Klarenbeek; Alwin Kamermans; F David Horgen; Andrea Fleig; Frank N van Leeuwen; Kees Jalink
Journal:  Cell Calcium       Date:  2013-10-16       Impact factor: 6.817

3.  Action potentials in primary osteoblasts and in the MG-63 osteoblast-like cell line.

Authors:  Maria Pangalos; Willem Bintig; Barbara Schlingmann; Frank Feyerabend; Frank Witte; Daniela Begandt; Alexander Heisterkamp; Anaclet Ngezahayo
Journal:  J Bioenerg Biomembr       Date:  2011-04-27       Impact factor: 2.945

4.  Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.

Authors:  Tian-Dong Leng; Ming-Hua Li; Jian-Feng Shen; Ming-Li Liu; Xin-Bo Li; Hua-Wei Sun; Debbie Branigan; Zhao Zeng; Hong-Fang Si; Jun Li; Jeff Chen; Zhi-Gang Xiong
Journal:  CNS Neurosci Ther       Date:  2014-12-01       Impact factor: 5.243

5.  TRPV4 participates in the establishment of trailing adhesions and directional persistence of migrating cells.

Authors:  Sanela Mrkonjić; Anna Garcia-Elias; Carlos Pardo-Pastor; Elsa Bazellières; Xavier Trepat; Joris Vriens; Debapriya Ghosh; Thomas Voets; Rubén Vicente; Miguel A Valverde
Journal:  Pflugers Arch       Date:  2015-01-06       Impact factor: 3.657

6.  TRPM7 regulates polarized cell movements.

Authors:  Li-Ting Su; Wei Liu; Hsiang-Chin Chen; Omayra González-Pagán; Raymond Habas; Loren W Runnels
Journal:  Biochem J       Date:  2011-03-15       Impact factor: 3.857

7.  MgO-doped tantalum coating on Ti: microstructural study and biocompatibility evaluation.

Authors:  Mangal Roy; Vamsi Krishna Balla; Amit Bandyopadhyay; Susmita Bose
Journal:  ACS Appl Mater Interfaces       Date:  2012-01-24       Impact factor: 9.229

8.  Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels.

Authors:  Susanna Zierler; Guangmin Yao; Zheng Zhang; W Cedric Kuo; Peter Pörzgen; Reinhold Penner; F David Horgen; Andrea Fleig
Journal:  J Biol Chem       Date:  2011-09-16       Impact factor: 5.157

Review 9.  Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?

Authors:  Tiandong Leng; Yejie Shi; Zhi-Gang Xiong; Dandan Sun
Journal:  Prog Neurobiol       Date:  2014-01-24       Impact factor: 11.685

10.  TRPM7 is regulated by halides through its kinase domain.

Authors:  Haijie Yu; Zheng Zhang; Annette Lis; Reinhold Penner; Andrea Fleig
Journal:  Cell Mol Life Sci       Date:  2013-03-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.